T85.82
Fibrosis due to internal prosthetic devices, implants and grafts, not elsewhere classified
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibrosis due to internal prosthetic devices, implants, and grafts (ICD-10 code T85.82) refers to the formation of excess fibrous tissue around medical implants inside the body. This condition can occur after surgical procedures involving prosthetic devices and may affect the function and longevity of the implants. It is a relatively uncommon but important complication to recognize and understand for those with internal medical devices.
Causes & Symptoms
Clinical Causes: Foreign body response: The body's natural immune response to a foreign object such as an implanted device can trigger tissue healing processes that result in fibrosis. Infection: An infection related to the implant can exacerbate tissue repair and lead to increased fibrous tissue formation. Repetitive mechanical stress or movement: Continuous movement or stress on the implant site can cause inflammation, which can promote fibrosis. Material hypersensitivity or allergy: Some individuals may have an allergic or hypersensitive reaction to the implant materials, potentially leading to fibrotic tissue growth. Poor surgical technique or complications: Incomplete removal of residual tissue or improper implant placement can contribute to fibrosis development. Chronic inflammation: Ongoing inflammation at the site of the implant encourages fibroblast proliferation and fibrous tissue formation.
Key Symptoms: Localized swelling or firmness near the implant site Pain or discomfort during movement or pressure on the affected area Restricted movement of nearby joints or tissues Visible or palpable thickening or scarring Potential signs of infection such as redness, warmth, or discharge (if infection is present)
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibrosis related to internal prosthetic devices involves a combination of clinical evaluation and imaging studies. Medical history regarding the placement of the implant is essential. Imaging techniques such as ultrasound, MRI, or CT scans can help visualize the extent of fibrous tissue proliferation. In certain cases, tissue biopsy may be performed to confirm fibrosis and rule out other complications like infection or neoplasm.
Treatment Protocols: Management of device-associated fibrosis aims to alleviate symptoms and prevent further tissue buildup. Treatment options include: - Medical therapy: Use of medications such as anti-inflammatory drugs or corticosteroids to reduce inflammation and fibrosis. - Physical therapy: Techniques to improve mobility and reduce tissue stiffness. - Surgical intervention: Removal or revision of the implant and excision of excess fibrous tissue may be necessary in severe cases. - Addressing underlying causes: Treating any infections or hypersensitivity reactions to minimize ongoing fibrosis. Early diagnosis and management are crucial to maintain the functionality of the implant and improve patient comfort.
Clinical Advice & FAQs
Billing Guidance
Is T85.82 a billable ICD-10 code?
Yes, T85.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T85.82?
Clinical documentation must specify the nature of Fibrosis due to internal prosthetic devices, implants and grafts, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference